Phase II Study of Bolus 5-Fluorouracil and Leucovorin Combined with Weekly Paclitaxel as First-Line Therapy for Advanced Gastric Cancer

Objective: We evaluated the efficacy and safety of bolus 5-fluorouracil (5-FU) and leucovorin combined with weekly paclitaxel (FLTAX) in advanced gastric cancer (GC) patients.

Keywords:

• Fluorouracil
• Cancer
• Febrile neutropenia
• Bolus (digestion)
• Progression-free survival
• Phases of clinical research
• Paclitaxel
• Medicine
• Internal medicine
• Oncology
• Chemotherapy
• weekly paclitaxel
• first line therapy
• advanced gastric cancer

• Correction
• Source
• Cite
• Save
• Machine Reading By IdeaReader